Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Sleep Apnea Video Education for CPAP (SAVE-CPAP)

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Other: Usual education
Other: Enhanced education
Other: Usual follow up
Other: Enhanced follow up

First Posted Date: 2015-09-17

Last Posted Date: 2017-03-03

Lead Sponsor: University of Chicago

Target Recruit Count: 212

Registration Number: NCT02553694

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Device: Deep Brain Stimulation (DBS) at 60 Hz
Device: Deep Brain Stimulation (DBS) at 130 Hz
Device: Deep Brain Stimulation (DBS) Off (Sham)

First Posted Date: 2015-09-15

Last Posted Date: 2020-10-29

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT02549859

Locations: 🇺🇸
University of Chicago, Department of Neurology, Chicago, Illinois, United States

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Not Applicable

Terminated

Conditions: Metastatic Renal Cell Cancer
Recurrent Renal Cell Carcinoma
Stage IV Renal Cell Cancer

Interventions: Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2015-09-04

Last Posted Date: 2024-05-30

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT02542202

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Phase 1

Completed

Conditions: Unresectable Malignant Neoplasm
Solid Neoplasm
Metastatic Malignant Neoplasm

Interventions: Drug: Ilorasertib
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-09-04

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT02540876

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Vortioxetine for Binge Eating Disorder

Phase 2

Completed

Conditions: Binge Eating Disorder

Interventions: Drug: Placebo
Drug: Vortioxetine

First Posted Date: 2015-08-19

Last Posted Date: 2020-11-23

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT02528409

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Intervention for Pre-Frailty and Frailty in Thoracic Surgery Patients

Not Applicable

Completed

Conditions: Frailty

Interventions: Other: Physical Therapy

First Posted Date: 2015-08-13

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 7

Registration Number: NCT02522533

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

rPlan Multimedia Dual Protection Intervention to Reduce Health Disparities

Not Applicable

Completed

Conditions: Sexually Transmitted Infection

Interventions: Behavioral: rPlan dual protection waiting room app intervention

First Posted Date: 2015-07-15

Last Posted Date: 2020-08-18

Lead Sponsor: University of Chicago

Target Recruit Count: 104

Registration Number: NCT02498067

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Individual Differences in the Response to Drugs

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: THC
Drug: AMP
Drug: ALC
Drug: Placebo capsules
Drug: Placebo beverage

First Posted Date: 2015-06-30

Last Posted Date: 2016-11-29

Lead Sponsor: University of Chicago

Target Recruit Count: 28

Registration Number: NCT02485158

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
de Novo Myelodysplastic Syndrome
Myelodysplastic Syndrome
Secondary Acute Myeloid Leukemia
Secondary Myelodysplastic Syndrome

Interventions: Other: Laboratory Biomarker Analysis
Drug: Selinexor

First Posted Date: 2015-06-30

Last Posted Date: 2021-05-13

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT02485535

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Coagulation Profile Surrounding Normal Cesarean Delivery

Completed

Conditions: Pregnancy

First Posted Date: 2015-06-26

Last Posted Date: 2015-12-02

Lead Sponsor: University of Chicago

Target Recruit Count: 10

Registration Number: NCT02482246

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy